These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23058913)

  • 1. Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome.
    Huber-Ruano I; Errasti-Murugarren E; Godoy V; Vera Á; Andreu AL; Garcia-Arumi E; Martí R; Pastor-Anglada M
    Biochem Biophys Res Commun; 2012 Nov; 428(4):532-7. PubMed ID: 23058913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H syndrome: the first 79 patients.
    Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
    J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H syndrome: novel and recurrent mutations in SLC29A3.
    Priya TP; Philip N; Molho-Pessach V; Busa T; Dalal A; Zlotogorski A
    Br J Dermatol; 2010 May; 162(5):1132-4. PubMed ID: 20199539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.
    Riachi M; Bas F; Darendeliler F; Hussain K
    Pediatr Diabetes; 2019 Jun; 20(4):474-481. PubMed ID: 30821020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
    Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
    Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
    Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
    Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the clinical spectrum of SLC29A3 gene defects.
    Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
    Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
    Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
    PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
    de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
    Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel homozygous frameshift mutation in SLC29A3 gene in a case with H syndrome from Iran.
    Bagherian R; Yousefipour F; Mousavi HS; Saffari F; HajiShafieha E; Mohammadi SN; Mousakhani H; Fathi SM; Mehrtash A; Verki FM; Lee D; Heidari A
    Curr Res Transl Med; 2019 May; 67(2):72-75. PubMed ID: 30723056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Histochemical, and Molecular Study of Three Turkish Siblings Diagnosed with H Syndrome, and Literature Review.
    Simsek E; Simsek T; Eren M; Yilmaz E; Arik D; Cilingir O; Ceylaner S; Harmancı K
    Horm Res Paediatr; 2019; 91(5):346-355. PubMed ID: 30625464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The H syndrome is caused by mutations in the nucleoside transporter hENT3.
    Molho-Pessach V; Lerer I; Abeliovich D; Agha Z; Abu Libdeh A; Broshtilova V; Elpeleg O; Zlotogorski A
    Am J Hum Genet; 2008 Oct; 83(4):529-34. PubMed ID: 18940313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agenesis of the inferior vena cava in H syndrome due to a novel SLC29A3 mutation.
    Mutlu GY; Ramot Y; Babaoglu K; Altun G; Zlotogorski A; Molho-Pessach V
    Pediatr Dermatol; 2013; 30(5):e70-3. PubMed ID: 23406517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.
    Ma H; Qu J; Liao Y; Liu L; Yan M; Wei Y; Xu W; Luo J; Dai Y; Pang Z; Qu Q
    Exp Cell Res; 2024 Jan; 434(2):113892. PubMed ID: 38104646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
    Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
    Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygous SLC29A3 mutation causes H syndrome in a Moroccan patient: A case report.
    Bakhchane A; Kindil Z; Charoute H; Benchikhi K; Khadir K; Nadifi S; Baline K; Roky R; Barakat A
    Curr Res Transl Med; 2016; 64(2):65-8. PubMed ID: 27316388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H syndrome: A histiocytosis-lymphadenopathy plus syndrome. A comprehensive review of the literature.
    Hamad A; Elwaheidi H; Salameh F; Alyahya M; El Fakih R; Aljurf M
    Hematol Oncol Stem Cell Ther; 2024 Jul-Sep 01; 17(3):159-167. PubMed ID: 39412751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H syndrome.
    El-Khateeb EA
    Pediatr Dermatol; 2010; 27(1):65-8. PubMed ID: 20199414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.